Journal
ANNALS OF NUCLEAR MEDICINE
Volume 29, Issue 1, Pages 1-7Publisher
SPRINGER
DOI: 10.1007/s12149-014-0898-6
Keywords
Neuroendocrine tumor; Theranostic; SPECT/CT; PET/CT; PRRT; Radionuclide therapy
Ask authors/readers for more resources
Abundant expression of somatostatin receptors (SSTR) is frequently identified in differentiated neuroendocrine tumors and may serve as potential target for diagnostic imaging and treatment. This article discusses the theranostic approach of SSTR-targeting compounds including an overview of its role for diagnosis, staging and restaging, discussing its way to being established in clinical routine, and giving an outlook about further potentially relevant developments.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
